Derivative exercise or conversion — not an open-market buy.
Loading…
Transaction Nov 19, 2025 · Disclosed Dec 29, 2025
Held by the filer's joint per the disclosure. Disclosed 40 days after the transaction; reported as an official range, not an exact amount.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
$1,001 - $15,000
Official band as filed. No midpoint or exact amount is implied
Joint
40 days
Days between the transaction date and the filing date
First disclosure on this company by this filer
No other filers within 90 days
Sponsored 13 bills in Health this Congress.
Bills (H.R. / S.) this member sponsored in the 119th Congress so far, including any introduced after the trade, grouped by the policy area the Congressional Research Service assigned (Congress.gov). Which policy areas relate to which sectors is OQRO's editorial mapping. Not a sign of what they knew or why they traded
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$87K of Edwards Lifesciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
